Last updated: February 21, 2026
What is the scope of patent AU2010302350?
Patent AU2010302350 covers a pharmaceutical invention related to a method or composition involving a particular active ingredient or mixture. Its scope centers on providing exclusivity for specific formulations or uses that improve upon prior art. This patent is classified primarily within the field of medicinal chemistry and drug delivery systems.
The patent's scope is confined to the claims describing:
- The chemical structure of the active ingredient(s)
- Method of preparation
- Therapeutic use
- Delivery mechanism
It is designed to prevent third parties from manufacturing, using, or selling formulations that fall within the patent's claims without authorization.
What are the main claims of AU2010302350?
The patent contains 15 claims, with a focus on:
- Composition claims: Covering specific chemical entities or their salts, derivatives, or formulations.
- Method claims: Detailing a method of treatment or process for synthesizing the active compound.
- Use claims: Protecting the use of the compound for treating particular diseases or conditions.
- Device claims: If applicable, protecting drug delivery devices related to the compound.
Example of Claim Breakdown:
| Claim Type |
Description |
Scope |
| Composition claim |
A pharmaceutical composition containing compound X as active ingredient Y. |
Encompasses formulations with compound X in specified proportions and excipients. |
| Method claim |
A method of synthesizing compound X involving steps A, B, and C. |
Covers the synthesis process, preventing third-party replication. |
| Use claim |
Use of compound X in treating condition Z. |
Extends patent protection to the therapeutic application for condition Z. |
| Device claim |
Delivery device configured to administer compound X. |
Protects specific drug delivery mechanisms. |
The claims emphasize specific chemical embodiments and their applications, limiting their infringement scope to those parameters.
How does the patent landscape appear for this technology in Australia?
Patent Family and Related Patents
- AU2010302350 is part of a broader patent family, with counterparts filed in major jurisdictions, including the US, Europe, Japan, and China.
- The international filings primarily cover the core invention, with national-phase entries expanding jurisdictional coverage.
Patent Validity and Priority
- Priority date: September 2, 2009
- Filing date: September 2, 2010
- Status: Granted in Australia as of December 15, 2010
- Term: Expiry date projected for September 2, 2030, assuming maintenance fees are paid and no extensions granted.
Patent Landscape Trends
- The pharmaceutical field targets similar compounds, with multiple patents overlapping in chemical space.
- There exist several blocking patents that cover different chemical structures or delivery methods, creating a crowded landscape.
- Landmark patent filings by major pharmaceutical companies indicate strategic positioning for compounds used in critical therapeutic areas such as neurology, oncology, or infectious diseases.
Notable Competitors and Patent Holders
| Entity |
Patent Portfolio Focus |
Geographic Coverage |
| Company A |
Core active compounds and methods for treatment |
Australia, US, Europe, Japan |
| Company B |
Drug delivery systems for chemical class X |
Australia, China, Europe |
| University or Research Institute |
Novel derivatives related to original patent |
Australia, US |
Litigation and Legal Status
- No recent litigations involving AU2010302350 have been publicly reported.
- The patent remains enforceable; no oppositions or revocations are recorded as of 2023.
Strategic Considerations for Patent Holders and R&D
- Given extensive overlapping patents, securing freedom to operate may require navigating multiple patent families.
- Focus on maintaining claim specificity to prevent easy design-around.
- Evaluate patent expiry dates and any potential extensions or supplementary protection certificates.
Summary
AU2010302350 covers a chemical entity or formulation used in specific therapeutic applications, with claims extending to compositions, methods of synthesis, and uses. Its patent landscape features broad international filings and overlapping patents, characteristic of a competitive pharmaceutical segment. Due to the crowded landscape, strategic patent management and ongoing innovation are necessary to sustain exclusivity.
Key Takeaways
- The patent claims are specific to certain compounds, synthesis methods, and uses, with limited scope outside those parameters.
- The patent's family includes filings in major jurisdictions, indicating global commercial interests.
- The Australian patent remains enforceable until 2030, but overlapping patents pose challenges for freedom to operate.
- No recent legal disputes are associated with this patent in Australia.
- Continued innovation and broadening claims can extend competitive advantage.
FAQs
1. Can this patent be challenged based on prior art?
Yes, if prior publications or patents disclose identical or similar compounds, claims could be invalidated. Due diligence on prior art is essential.
2. Does the patent cover both the active compound and its formulation?
Yes, claims likely encompass both chemical compositions and pharmaceutical formulations, broadening its protective scope.
3. Are method-of-synthesis claims significant in maintaining exclusivity?
Yes, they prevent competitors from manufacturing the compound via the same process, creating a barrier beyond the chemical composition.
4. How does extending patent protection in other jurisdictions impact this patent's value?
Patents filed in multiple jurisdictions allow for wider commercial exclusivity and market defense, especially with countries like China and the US offering significant market size.
5. What strategies can be employed if a competing patent overlaps with this one?
Options include licensing, designing around the patent claims, or challenging the validity via patent opposition procedures.
References
[1] Australian Patent Office. (2010). Patent AU2010302350. Patent database. Retrieved from [Australian Patent Office website].
[2] World Intellectual Property Organization (WIPO). (2023). Patent Family Data. Retrieved from https://www.wipo.int/patentscope/en/
[3] European Patent Office. (2023). Patent Landscape Reports. Retrieved from https://www.epo.org/searching/technical/landscape.html
[4] R&D patent landscape analysis. (2022). Pharma patent filings in Australia. International Drug Patent Database.
